Inhibrx, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Inhibrx, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Inhibrx, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $146M, a 59.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $146M +$54.4M +59.4% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $91.6M +$33.1M +56.5% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $58.5M +$19.4M +49.7% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $39.1M +$11.2M +39.9% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $27.9M Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.